1 |
Alon R, Feigelson SW (2012). Chemokine-triggered leukocyte arrest: force-regulated bi-directional integrin activation in quantal adhesive contacts. Curr Opin Cell Biol, 24, 670-6.
DOI
|
2 |
Barrett T, Wilhite SE, Ledoux P, et al (2013). NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res, 41, 991-5.
DOI
|
3 |
Biometric Research Branch home page (2015c).
|
4 |
Breast Cancer Treatment (2015b). (PDQ(R)) - National Library of Medicine - PubMed Health.
|
5 |
Christopher MJ, Rao M, Liu F, et al (2011). Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med, 208, 251-60.
DOI
|
6 |
de la Puente P, Muz B, Azab F, et al (2013). Cell trafficking of endothelial progenitor cells in tumor progression. Clin Cancer Res, 19, 3360-8.
DOI
|
7 |
Ding Y, Shen J, Zhang G, et al (2015). CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer. Oncotarget, 6, 38901-11.
DOI
|
8 |
Domanska UM, Kruizinga RC, Nagengast WB, et al (2013). A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur J Cancer, 49, 219-30.
DOI
|
9 |
Ellem SJ, Taylor RA, Furic L, et al (2014). A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment. J Pathol, 234, 86-98.
DOI
|
10 |
Finak G, Bertos N, Pepin F, et al (2008a). Stromal gene expression predicts clinical outcome in breast cancer. Nat Med, 14, 518-27.
DOI
|
11 |
Franceschini A, Szklarczyk D, Frankild S, et al (2013). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res, 41, 808-15.
DOI
|
12 |
Gil M, Komorowski MP, Seshadri M, et al (2014). CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells. J Immunol, 193, 5327-37.
DOI
|
13 |
Hiratsuka S, Duda DG, Huang Y, et al (2011). C-X-C receptor type 4 promotes metastasis by activating p38 mitogenactivated protein kinase in myeloid differentiation antigen(Gr-1)-positive cells. Proc Natl Acad Sci U S A, 108, 302-307.
DOI
|
14 |
Graeber TG, Eisenberg D (2001). Bioinformatic identification of potential autocrine signaling loops in cancers from gene expression profiles. Nat Genet, 29, 295-300.
DOI
|
15 |
Hanahan D, Coussens LM (2012). Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell, 21, 309-22.
DOI
|
16 |
Hattori K, Heissig B, Tashiro K, et al (2001). Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood, 97, 3354-60.
DOI
|
17 |
Huang DW, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
DOI
|
18 |
Irizarry RA, Hobbs B, Collin F, et al (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-64.
DOI
|
19 |
Joyce JA, Fearon DT (2015). T cell exclusion, immune privilege, and the tumor microenvironment. Science, 348, 74-80.
DOI
|
20 |
Kuehn C, Vermette P, Fulop T (2014). Cross talk between the extracellular matrix and the immune system in the context of endocrine pancreatic islet transplantation. A review article. Pathol Biol (Paris), 62, 67-78.
DOI
|
21 |
Kwast AB, Voogd AC, Menke-Pluijmers MB, et al (2014). Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat, 145, 503-11.
DOI
|
22 |
Maenhout SK, Thielemans K, Aerts JL (2014). Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloidderived suppressor cells. Oncoimmunol, 3, 956579.
DOI
|
23 |
LaBreche HG, Nevins JR, Huang E (2011). Integrating factor analysis and a transgenic mouse model to reveal a peripheral blood predictor of breast tumors. Bmc Med Genomics, 4, 61.
DOI
|
24 |
Ley K, Laudanna C, Cybulsky MI, et al (2007). Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol, 7, 678-89.
DOI
|
25 |
Lourenco S, Teixeira VH, Kalber T, et al (2015). Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors. J Immunol, 194, 3463-74.
DOI
|
26 |
McAllister SS, Weinberg RA (2014a). The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol, 16, 717-27.
DOI
|
27 |
McAllister SS, Weinberg RA (2014b). The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol, 16, 717-27.
DOI
|
28 |
Orimo A, Gupta PB, Sgroi DC, et al (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-48.
DOI
|
29 |
Quail DF, Joyce JA (2013). Microenvironmental regulation of tumor progression and metastasis. Nat Med, 19, 1423-37.
DOI
|
30 |
Schmid MC, Franco I, Kang SW, et al (2013). PI3-kinase gamma promotes Rap1a-mediated activation of myeloid cell integrin alpha4beta1, leading to tumor inflammation and growth. Plos One, 8, 60226.
DOI
|
31 |
Shetty S, Bruns T, Weston CJ, et al (2012). Recruitment mechanisms of primary and malignant B cells to the human liver. Hepatol, 56, 1521-31.
DOI
|
32 |
Seubert B, Grunwald B, Kobuch J, et al (2015). Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatol, 61, 238-48.
DOI
|
33 |
Shaked Y, McAllister S, Fainaru O, et al (2014). Tumor dormancy and the angiogenic switch: possible implications of bone marrow- derived cells. Curr Pharm Des, 20, 4920-33.
DOI
|
34 |
Shannon P, Markiel A, Ozier O, et al (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-504.
DOI
|
35 |
Song N, Choi JY, Sung H, et al (2015). Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes. Plos One, 10, 122413.
|
36 |
Spaeth E, Klopp A, Dembinski J, et al (2008). Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther, 15, 730-8.
DOI
|
37 |
Tusher VG, Tibshirani R, Chu G (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A, 98, 5116-21.
DOI
|
38 |
UniProt (2015d). a hub for protein information. Nucleic Acids Res, 43, 204-12.
DOI
|
39 |
WHO (2015a). Breast cancer: prevention and control.
|
40 |
Zhang QQ, Hu XW, Liu YL, et al (2015). CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Sci Rep, 5, 15948.
DOI
|